Navigation Links
FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder
Date:11/20/2008

PHILADELPHIA, Nov. 20 /PRNewswire-FirstCall/ --GlaxoSmithKline (NYSE: GSK) today announced that the United States Food and Drug Administration (FDA) granted accelerated approval for PROMACTA(R) (eltrombopag) for the treatment of thrombocytopenia in patients with chronic immune (idiopathic) thrombocytopenic purpura (ITP) who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy. The approval is a significant milestone for PROMACTA and the ITP community, as PROMACTA is the first oral thrombopoietin (TPO) receptor agonist approved for adult patients with chronic ITP. GSK expects PROMACTA to be available by the next week.

"It is very important for chronic ITP patients to have new treatment options to manage the symptoms of this serious and, at times, life-threatening disease. In addition, many people with chronic ITP are concerned about everyday activities for fear of an accidental bump or unanticipated bruise that may lead to bleeding," said Craig Conway, executive director of the Platelet Disorder Support Association. "The approval of this new product represents a promising new treatment option that offers hope to the ITP community."

Shift in Approach

"Preventing platelet destruction has always been the primary means of treating patients with ITP. Recent advances, like the clinical trials of PROMACTA, show that increasing the production of platelets may also play a significant role in treating this disorder," said James Bussel, M.D., director of the Platelet Disorders Center, Children's Cancer and Blood Foundation Division of New York Presbyterian/Weill Cornell Medical Center. "The entire ITP community, including physicians, patients and their families, may benefit from this shift in thinking and these innovative new treatments."

'/>"/>
SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... N.C. , May 22, 2013 STEPh, ... to announce the launch of their web site ( ... [STEPh Reports].  About STEPh Reports ... in development.  Each STEPh Report assesses ... trials data, projected launch year, company, and specific key ...
(Date:5/22/2013)... MEDIFIRST SOLUTIONS, INC. (OTCQB: MFST) would like ... recent company developments. As Medifirst continues to expand its ... shareholders. Integrating social media into its investor relations strategy, ... post updates on Twitter.  The Facebook homepage is Medifirst ... Says CEO Bruce J. Schoengood ...
(Date:5/22/2013)... 2013 Ranbaxy Laboratories Limited (hereafter, Ranbaxy), ... Daiichi Sankyo), announced on May 22 the actions ... address past conduct under prior management ... Sankyo continues to support Ranbaxy in its efforts ... past which led to the investigations by the ...
Breaking Medicine Technology:Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Launches New Competitive Intelligence Web Site 2Medifirst Solutions, Inc. Announces Update To Shareholders 2
(Date:5/22/2013)... (PRWEB) May 22, 2013 College ... have access to Adapt Courseware’s new Introduction ... an adaptive framework that responds based on each ... , the provider of comprehensive adaptive online curriculum ... continuing to develop introductory level general education offerings, ...
(Date:5/22/2013)... May 22, 2013 Beginning Aug. 22, ... the Conrad Foundation’s Spirit of Innovation Challenge . ... plan competition, free and open to students ages 13 ... Spirit of Innovation Challenge celebrates the life and entrepreneurial ... on the Moon. The program challenges teens to work ...
(Date:5/22/2013)... health officials from New Zealand, South Africa, Australia, Fiji ... countries to integrate rheumatic fever (RF) and rheumatic heart ... , "RHD was nearly eradicated in wealthy populations at ... a disease of poverty that kills children, adolescents and ... K. Srinath Reddy, President of the World Heart Federation. ...
(Date:5/22/2013)... TUESDAY, May 21 (HealthDay News) -- The overall health ... 10 people either overweight or obese and large numbers ... not exercising, a new government report shows. , , ... and Prevention, the report found Americans continuing to make ... soaring rates of heart disease, diabetes and other chronic ...
(Date:5/22/2013)... of Melbourne said this small increase in cancer risk ... scans in diagnosing and monitoring disease. , The study ... today and involved researchers at eight other centres ... Research on Cancer in Lyon, France. , Professor ... detailed three dimensional pictures to diagnose or exclude disease ...
Breaking Medicine News(10 mins):Health News:Adapt Courseware Releases Introduction to Sociology for Colleges and Universities Nationwide 2Health News:Adapt Courseware Releases Introduction to Sociology for Colleges and Universities Nationwide 3Health News:Conrad Foundation Announces 2013-2014 Spirit of Innovation Challenge Launch Date 2Health News:Governments hold long-overdue meeting on reducing early death from rheumatic heart disease 2Health News:Americans Still Making Unhealthy Choices: CDC 2Health News:Americans Still Making Unhealthy Choices: CDC 3Health News:Small increase in cancer risk following CT scans in childhood and adolescence 2
... (Nasdaq: ISIS ) announced that the Company will ... San Francisco, CA. Stanley T. Crooke, M.D., Ph.D., Chairman ... Company and an update on recent clinical and business activities.The ... on Monday, January 12, 2009. To access the live ...
... the leading,publisher of medical and scientific literature, announced ... American College of Cardiology,(ACC) ( http://www.acc.org ), the ... research. The agreement calls for Elsevier to publish,the ... of Cardiology,(JACC) ( http://www.elsevier.com/locate/jac ), for the ...
... hearty compared to other industries that have experienced massive layoffs lately. ... jobs in a single week, bringing the site,s job count to ... nursing profession, NursingCrossing aims to update its website with each and ... ...
... Jan. 8 Press Ganey Associates, Inc.,today announced ... of patient flow management tools and services for ... by,offering strategic solutions for patient flow issues such ... delayed surgeries, and lack of,available ICU and hospital ...
... Natural Alternatives International, Inc. ("NAI") (Nasdaq: ... marketer of customized nutritional supplements, today announced that ... Weaver,s employment with NAI ended.NAI also announced it ... Wells Fargo Bank. Among other changes the ...
... at Protecting Medicare Beneficiaries Introduced on the First ... Physical therapy services for ... arbitrary financial caps under legislation introduced Tuesday in ... the American Physical Therapy Association (APTA). The Medicare ...
Cached Medicine News:Health News:Isis Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference 2Health News:The American College of Cardiology Renews its Publishing Partnership With Elsevier 2Health News:The American College of Cardiology Renews its Publishing Partnership With Elsevier 3Health News:NursingCrossing Posts 12,000-Plus Nursing Jobs in a Week; Stresses the Need for Better Training and Working Conditions for Nurses 2Health News:NursingCrossing Posts 12,000-Plus Nursing Jobs in a Week; Stresses the Need for Better Training and Working Conditions for Nurses 3Health News:Press Ganey Acquires PatientFlow Technology 2Health News:Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension 2Health News:Senate and House Introduce Legislation to Repeal Therapy Caps 2Health News:Senate and House Introduce Legislation to Repeal Therapy Caps 3
... the hand, the Jarvik 2000 pump is about ... welded titanium shell sits a direct-current motor, a ... single moving part: a small, spinning titanium impeller ... to 7 liters per minute. Rather than take ...
... cardiac assist system primarily designed as a permanent ... failure., ,It is a blood pump that connects ... to help the ailing hearts pumping function and ... , ,It can also be used as a ...
... The Masimo SET LNOP Blue Sensor is ... babies. The LNOP Blue sensor is ... accuracy claims for cyanotic infants and children. ... presented challenging conditions for reliable and accurate ...
... The Trinity Biotech Captia™ Varicella-Zoster Virus (VZV) ... for the detection and quantitative determination of ... Individual serum specimens may be used for ... acute and convalescent, may be used to ...
Medicine Products: